Prognostic significance of splicing factor gene mutations in AML; therapy resistance in multiple myeloma; the effects of KIT ligand deletion on HSC homeostasis
Blood Podcast
00:00
Multi-Omics Approach in Evaluating Cells in Multiple Myeloma
This chapter discusses the use of a multi-omics approach to assess treatments and compare targeted therapies with immunotherapies in multiple myeloma. The limitations of this approach and the potential use of spatial technologies and combining sequencing data are explored.
Transcript
Play full episode
